
- Telehealth Visits
- Insurance plan information

Esther A. Kim, MD
Reconstructive Plastic Surgery • Gender SurgeryChief, Gender Affirming Surgery- Telehealth Visits
- Insurance plan information



Esther A. Kim, MD
Reconstructive Plastic Surgery • Gender SurgeryChief, Gender Affirming Surgery- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Esther A. Kim is a plastic surgeon specializing in cosmetic and complex reconstructive surgery. She performs surgical and nonsurgical injectable cosmetic procedures, microvascular breast reconstruction (advanced reconstruction techniques that have several advantages for patients) and gender affirmation surgery. Her goal is to achieve natural-looking results and optimal outcomes through attention to detail. Combining technical excellence, an artistic eye and compassionate care, she takes each patient's needs and anatomic differences into account to achieve the best outcome.
Kim's research focuses on health care disparities and ways to improve quality of life and surgical outcomes for patients who undergo reconstructive and cosmetic surgery.
Kim earned her medical degree from the University of California, Davis. She completed a residency in general surgery at the University of Nebraska Medical Center, followed by a residency in plastic surgery at the Mayo Clinic in Scottsdale, Arizona. At UCSF, she completed a fellowship in microsurgery (especially delicate procedures performed under a microscope), and she now serves as co-director of this fellowship program. She strives to balance a professional career, service to her community and serving as a role model to her three daughters.
Education & training
Board certification
- Plastic Surgery, American Board of Plastic Surgery
Residency
- Plastic Surgery, Mayo Clinic Hospital GME (Phoenix, AZ)
- University of Nebraska Medical Center
Internship
- University of Nebraska Medical Center
Degree
- MD, University of California Davis School of Medicine
My expertise
Specialties
- Reconstructive Plastic Surgery
- Gender Surgery
- Plastic Surgery
- Microvascular Plastic Surgery
- Aesthetic Plastic Surgery
Locations
My research
Clinical trials
Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming MastectomyOpens in a new window
Recruiting
Hematoma will be defined as a collection of blood outside of blood vessels that requires intervention such as aspiration or surgical drainage. Hematomas that…Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming MastectomyOpens in a new window
Recruiting
Presence or Absence of HTS: HTS defined as a raised, firm fibrotic lesion that develops within the boundaries of surgical incision with a height cutoff of >/=…
Publications
Showing 1-6 of 20 reviews
- September 25, 20255 out of 5 Stars
Attentive, intelligent conversation, caring, superb team!
- September 2, 20255 out of 5 Stars
Dr. Kim has a great reputation, and I wasn't disappointed. I feel privileged to be under her care.
- May 6, 20255 out of 5 Stars
Dr Kim and the whole team always professional and kind.
- March 18, 20255 out of 5 Stars
Very professional
- February 17, 20252 out of 5 Stars
I found Dr. Kim to have very poor bedside manner. She told me multiple times that she didn't think I would be satisfied with having a gender affirming reduction. I asked multiple times what might be a good outcome, but she just kept repeating the same negative statement. I might still refer her to someone wanting top surgery, because it seems like she is more confident in that area, but I would definitely tell someone to expect poor bedside manner and not to see her if they want a reduction. I found her to be quite negative and cold.
- February 4, 20255 out of 5 Stars
Dr. Kim was great! Very professional and straight forward
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.